Beth E. Roxland, JD, M.Bioethics
Senior Consultant on Law, Health Policy and Ethics
Beth E. Roxland. J.D., M.Bioethics is a seasoned Attorney & Bioethicist with multifaceted experience across Industry, Law, Government & Academia. She founded an independent consultancy (Roxland Consultants Ltd.) to leverage her unique expertise to provide comprehensive but practical support and advice to life-science, biotechnology & research entities, law firms, hospitals & healthcare practitioners, venture capital & financial institutions, and professional & patient associations confronting complex legal, ethical, operational & communications challenges in the scientific and medical arenas. Beth is also a practicing attorney, specializing in litigation, regulation, policy, public health & pandemics, risk & crisis management, and insurance. Beth is a frequent public speaker & author, and serves on several academic, medical and research oversight boards, and occupies leadership roles in professional societies.
Beth’s prior Executive roles include serving as:
– Johnson & Johnson’s Bioethics and Strategy Leader, in the Global Chief Medical Officer’s Office;
– Executive Director of The New York State Task Force on Life & the Law;
– Special Advisor to the Commissioner of Health on Stem Cell Research Ethics;
– Federal Judicial Law Clerk in the Southern District of New York (S.D.N.Y.);
– Senior Litigation Associate at Simpson Thacher & Bartlett LLP; and
– Adjunct Professor of Law at NYU School of Law.
Beth graduated from Columbia University with a Bachelors degree in Biology, and from the University of Pennsylvania Magna Cum Laude with joint degrees in Law and Bioethics (J.D. – M.Bioethics).
Expertise:
POLICY: Expanded Access & Compassionate Use ~ CRISPR & genomics ~ stem cell & regenerative medicine policy and procedures ~ health tech & apps ~ Right to Try ~ charging and reimbursement for research interventions ~ Real World Evidence ~ Public Health ~ return of research results ~ biobanking ~ trial design & recruitment ~ subject compensation ~ IRB education & operations ~ research with special populations (eg, adults with Alzheimer’s or other capacity-impacting conditions) ~ data gathering, monitoring, & transparency ~ patient engagement ~ informed consent ~ genetically-modified (GMO) tech & labeling ~ medical tourism ~ Opioid Crisis ~ journal retractions
LAW: Litigation ~ regulation ~ contracts ~ life sciences/ food & drug law ~ drafting legislation and regulation for global and domestic governmental entites ~ privacy ~ insurance ~ healthcare ~ trademark & copyright ~ mass torts ~ white collar crime & internal investigations ~ arbitration & mediation ~ compliance ~ family law ~ conflicts of interest